Trials / Conditions / Relapsed Solid Neoplasm
Relapsed Solid Neoplasm
3 registered clinical trials studyying Relapsed Solid Neoplasm.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors NCT05060276 | Sorrento Therapeutics, Inc. | Phase 1 |
| Completed | A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling NCT04773782 | Blueprint Medicines Corporation | Phase 1 / Phase 2 |
| Unknown | Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors NCT04900519 | Sorrento Therapeutics, Inc. | Phase 1 |